Pharmaceutical Business review

Qua launches new Fractional Electrodeionization product range

FEDI-2Rx range is used in pharmaceutical, biomedical and laboratory applications where installations require hot water sanitization to meet pharmacopoeia standards for purified water and water for injection.

QUA Group technical director V J Nathan said that the company is ready to serve the pharma, medical, biomedical, cosmetics and laboratory arena after successful acceptance of its industrial range of FEDI.

"We are confident that our patented process of manufacturing ion exchange media will provide improved reliability of performance in these applications," Nathan added.

Qua’s FEDI technology with the patented dual voltage technology, is the next generation of electrodeionization technology for the production of pure water.